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journal homepage: www.elsevier .com/locate/pbiomolbioEditorialDynamic structures in DNA damage responses & cancerA singular triumph of structural biology came from the applica-
tion of diffractionphysics to the elucidation of theDNAdouble helix:
this atomic structuralmodel based upon low resolutionﬁber diffrac-
tion solved the mystery of genetic replication essential to life by
revealing DNA base pairing for accurate copying (Watson and
Crick, 1953). A singular missed implication of the double helix was
its critical value for the maintenance of genome integrity by allow-
ing accurate DNA damage repair (Crick, 1974). A third element
required for eukaryotic life, which has substantial genetic informa-
tion, is the long-range coordinated regulation of replication, tran-
scription, and repair events to avoid destructive interference and
consequent loss of critical genetic information (Hopfner et al., 2000).
Within recent years, advances in biophysical analyses and their
applications are addressing issues and uncovering challenges in
DNA replication, repair, and pathway coordination by providing
mechanistic knowledge connecting nucleic acideprotein com-
plexes to cellular pathways for genome integrity. As a reduction
in replication and repair ﬁdelity is involved in cancer etiology, can-
cer prognosis, and a target for cancer therapy (Helleday et al.,
2008), this biophysical data is timely and increasingly proving rele-
vant to cancer biology and therapeutics. To provide insights into
these advances, this volume of PBMB presents nine selections by
internationally leading investigators outlining recent progress
and unsolved problems concerning the structural and functional
basis of genome integrity. Biophysical approaches are increasingly
appreciated as essential to uncovering the mechanisms of damage
recognition and removal, and coordination of events in the context
of replication, transcription and epigenetic modiﬁcations. Although
coordination likely occurs in most biological pathways, the great
selective pressure to limit toxic andmutagenic loss of genetic integ-
rity means that DNA damage responses are especially informative
for biological studies of exquisite structural regulation of pathway
handoffs and coordination.
Papers in this issue grew out of the International Workshop on
Dynamic Structures in DNA Damage Responses & Cancer in 2014.
Insights resulting from the interactive exchange of results and ideas
at this conference are presented in a set of exemplary papers for
this themed volume of Progress in Biophysics and Molecular
Biology. This is an exciting and enabling period for advances in X-
ray structural analyses. The free electron laser (Cohen et al., 2014)
is enabling tiny crystals and time resolution in crystal structures.
Recent analysis of the R-factor gap between crystallographic
models and data has discovered untapped information on ﬂexible
regions and solvent in crystallographic data sets, suggesting an op-
portunity to substantially improve all existing macromolecular
structures by providing more accurate models (Holton et al.,http://dx.doi.org/10.1016/j.pbiomolbio.2015.04.003
0079-6107/© 2015 Published by Elsevier Ltd.2014). Advances in X-ray scattering, including the development of
a novel scattering invariant (Rambo and Tainer, 2013) and an objec-
tive measure of ﬂexibility (Rambo and Tainer, 2011), promise to in-
crease the accuracy of high throughput methods for analysis of
macromolecular conformations and assemblies in solution. The
many conformational states acting in genome integrity suggest
different conformations can give different outcomes, as shown for
Mre11 and Rad50 (Deshpande et al., 2014), implying that top
down methods often cannot predict outcomes from gene networks
alone and that bottom-up structural mechanisms can be critical to
predictive understanding of DNA damage responses.
Crystallography provides precise structures but limited infor-
mation about ﬂexibility (Putnam et al., 2007), although tempera-
ture factors can identify functionally ﬂexible regions when
corrected for crystal contacts (Tainer et al., 1984). Unveiling the
roles of ﬂexibility in DNA damage responses is an ongoing process
that would beneﬁt from continued methods development. Flexi-
bility for interaction and functional access to DNA ends makes
sense geometrically, and is seen in systems such as the DNA
ligase-PCNA interaction, where a linear ligase wraps around the
DNA ends like a molecular watch band (Pascal et al., 2006). Yet,
intra-molecular interactions of ﬂexible regions can contribute to
the stability of the folded region and can act in intermolecular
interaction, making interpretations of structures and their func-
tions challenging by single methods (Hegde et al., 2013). Thus, mul-
tiple biophysical techniques combined with molecular biology may
be crucial for a predictive understanding of functional ﬂexibility in
macromolecular machines.
In this context there is also increasing evidence for the great
value of speciﬁc inhibitors, which can be optimized from X-ray
structures (Garcin et al., 2008) and developed from structural ana-
lyses of fragment libraries (Winter et al., 2012). Notably, only 1 out
of 20 drugs for oncology makes it through clinical trials, and these
typically cost a stunning 2 billion dollars (see http://csdd.tufts.edu/
news/complete_story/pr_tufts_csdd_2014_cost_study (Fig. 1)).
Therefore the cost of an average novel cancer drug including fail-
ures may exceed ~10e20 billion dollars (Kola and Landis, 2004).
This current cost to success ratio for oncology is thus likely unsus-
tainable for pharmaceutical companies, so a mechanistic under-
standing linking structures to pathways and outcomes, which
may increase the percentage of drugs validated in clinical trials,
will have extremely high impact for science and public health.
The genome instability associated with most cancers is an
exploitable cancer target (Pearl et al., 2015). However, we need to
understand mechanisms of genome stability and instability more
completely before we can effectively exploit instability to improve
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combination of NMR, X-ray scattering, and insightful analysis is
revealing the nature of dynamic DNA processing machines that
control genome stability and are often built from multiple,
structurally-independent functional domains, as seen for RPA
(Mer et al., 2000). An important conceptual insight from this
work is that DNA repair complexes can coordinate activities by
forming hubs or keystone complexes that contact DNA and multi-
ple protein partners via modular interactions (Sugitani and
Chazin, 2015). The combination of multiple moderate (uM) binding
afﬁnities provides sufﬁcient afﬁnity for speciﬁcity while allowing
interface exchange and the handoff of DNA intermediates. DNA
repair is essential to cell biology, so active site chemistry and core
domains can be conserved among the three Domains of life. Yet,
the greater selective pressure to coordinate repair steps and path-
ways to avoid loss of genetic information in eukaryotes with their
larger chromosomes is evident in added regulatory interactions,
conformations, and post-translational modiﬁcations in human
DNA repair structures compared to those from bacteria and
archaea, as seen in the ﬂexible terminal extension of repair
nuclease APE1 (Hopfner et al., 2000). Transitions of the repair ma-
chinery employ interface competition and multi-domain allostery.
Technical advances in the production and analysis of dynamic func-
tional assemblies are enabling the understanding of both their ac-
tivities and coordination with other DNA transactions. These
results highlighting hubs suggest new strategies and different clas-
ses of cancer drug targets than active sites. Notably, disrupting
coordinating interactions and conformation can cause apoptosis
in cancer cells. Normal cells are typically distinguished from cancer
cells by retaining multiple layers of regulation that allow them to
halt replication and transcription and to employ alternative repair
pathways that may also be absent or defective in transformed cells.
The most common form of DNA damage is base damage
including deaminations, alkylations, and oxidations where the
chemical structure of the DNA is altered, so DNA base repair is cen-
tral to all life, and structures are uncovering elegantmechanisms for
this process (Hitomi et al., 2007). Deamination of the exocyclic
amines in adenine, guanine and cytosine forms base lesions that
can cause mutations due to non-canonical base pairs and misincor-
poration during replication. Both repair of deaminated DNA and
processing of functionally-important deamination of RNA in
humans is an important function for Endonuclease V (EndoV), as
elucidated by Dalhus et al. (2015), who consider the structural basis
for EndoV incision at deaminated adenines in DNA and RNA. In
contrast to DNA glycosylases that remove a damaged base by exci-
sion of the nucleobase, EndoV incises DNA at the second phospho-
diester 30 to base lesions without removing the deaminated base.
Structural investigation of this novel incision by EndoV shows that
a wedge motif promotes DNA strand-separation and separate
pockets recognize the ﬂipped out base lesion and phosphate back-
bone. Human EndoV, but not the bacterial homolog, incises RNA
substrates containing inosine, the deamination product of adeno-
sine, which is a frequent RNA modiﬁcation. Structural analyses of
EndoV are increasing our knowledge of EndoV activity, thus
providing comparative links between DNA repair and RNA process-
ing and promising to address unanswered questions regarding RNA
activities in the human enzyme.
Completion of DNA replication and repair pathways requires
ligation of the DNA ends (Tomkinson et al., 2013). Although DNA
ligase has conformational ﬂexibility to wrap around the DNA
(Pascal et al., 2006), the ligation reaction is completely blocked by
modiﬁed DNA ends, such as the products and repair intermediates
of DNA oxidation, alkylation, or the aberrant incorporation of ribo-
nucleotides into genomic DNA. Aborted DNA ligation reactions
create 50-adenylated DNA and RNA-DNA damage that is reversedby aprataxin (Aptx), a member of the histidine triad (HIT) super-
family. Aptx acts in single-stranded DNA repair through its
nucleotide-binding activity and its diadenosine polyphosphate hy-
drolase activity (Schellenberg et al., 2015). X-ray crystal structures
of Schizosaccharomyces pombe Aptx (SpAptx) and human
Aptxesubstrate complexes provide insights into Aptx recognition
of RNA-DNA, AMP lesions, and Zn cofactors (Schellenberg et al.,
2015). These structural analyses combined with molecular biology
data provide a critical molecular framework for a mechanistic
knowledge of the Aptx deadenylation reaction and for the linkage
of human APTX mutations to the neurological disorder Ataxia
with Oculomotor Apraxia 1 (AOA1). A detailed understanding of
the processing and control of DNA breaks to produce ends that
can be rejoined by DNA ligase to reestablish the unbroken DNA
double helix is critical to understanding DNA damage responses
and regulated repair synthesis.
Acting in replication fork rescue and homologous recombination
repair of DNA breaks, the human breast and ovarian cancer type 1
susceptibility (BRCA1) protein of 1863 residues has conserved
RING domain and tandem BRCT domains at its termini. These do-
mains recognize post-translational modiﬁcations and act in BRCA1
assembly into a stable heterodimer (Wu et al., 2015). The BRCA1
RING domain has E3 ubiquitin ligase activity. The BRCT domains
bind phosphorylated proteins during the DNA damage response to
coordinate repair and signaling. Importantly, informed structural an-
alyses are revealing protein partners, activities, and mechanisms
whereby mutational defects cause human disease. In particular,
the sites atwhich BRCA1-interacting proteins bind have been identi-
ﬁed. Furthermore, clinical mutations have been mapped, which
target the RING domains, disrupt the BRCA1 BRCT domain interac-
tion with phosphorylated proteins, and block the accumulation of
BRCA1 at damage-induced foci. Another mutation abrogates the
BRCA1E3 ubiquitin ligase activitywithout damaging theRING struc-
ture. In addition, cancer patient mutations at conserved residues on
the BRCA1 coiled-coil domain abrogate its interaction with partner
and localizer of BRCA2 (PALB2; also known as FANCN) and compro-
misehomologous recombination-mediatedDNArepair. This analysis
of interactions andmutations advances our understanding by exam-
ining themany structures of complexes for BRCA1-tandem-BRCTdo-
mains that include BACH1, BRCA1-interacting protein carboxy-
terminal helicase 1, and CtIP among others (Wu et al., 2015).
DNA-PKcs, a PI3/PI4-family member, was discovered as multi-
functional protein kinase (Lees-Miller and Anderson, 1989) that
we now know functions for both DNA double-strand break repair
and mitosis (Jette and Lees-Miller, 2015). It forms the catalytic sub-
unit of the DNA-dependent protein kinase (DNA-PK) that functions
withKu70/Ku80heterodimer inDNAdouble strand break repair and
Non-Homologous End Joining (NHEJ). Breakthrough crystal struc-
tures of a large fragment of DNA-PK (Sibanda et al., 2010) and of
the Ku-DNA complex (Walker et al., 2001) have opened the door
to X-ray scattering analyses and provided the framework for DNA-
PK structural and mutational analyses in mitosis (Jette and Lees-
Miller, 2015) as well as repair (Williams et al., 2014). Furthermore,
structures of the machinery that holds the DNA ends and channels
the pathway to ligase reveal howDNA-PKmay regulate the architec-
ture acting in NHEJ coordination. DNA-PKcs is autophosphorylated
on multiple sites in mitosis and dephosphorylated by protein phos-
phatase 6. DNA-PKcs is required for correct alignment of mitotic
chromosomes on the metaphase plate for accurate mitosis.
Emerging results suggest that the mechanism of activation of
DNAPKcs in mitosis may be Ku-independent and distinct from
that in NHEJ. It will be exciting to decipher the different molecular
mechanisms for DNA-PKcs activities inmitosis and inNHEJ to better
understand the functions for this DNA-dependent kinase that is far
more highly expressed in humans than in other mammals.
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otic transcription factor complex TFIIH, and has dual roles in tran-
scription and DNA repair (Fuss and Tainer, 2011). Structure-based
analyses of XPB (Fan and Du Prez, 2015) reveal functional motifs
and architectures for its activities in opening the DNA promoter
to initiate RNA polymerase II transcription and in further opening
dsDNA ﬂanking a DNA lesion to initiate nucleotide excision repair
(NER). Among the questions under current investigation involve
the ability of NER to remove diverse, structurally-unrelated DNA
helix-distorting lesions. The key role played by XPB is evident
from the severe clinical consequences of inherited defects in XPB
including cancer prone Xeroderma Pigmentosum (XP), defective
development in Cockayne Syndrome (CS), their combination in
XP and CS (XP/CS), and rapid aging in Trichothiodystrophy (TTD).
The relationships of XPB defects and particular diseases are open
questions under investigation. In the companion TFIIH helicase
XPD, the structural implications of patientmutations are that XP re-
sults from defects in DNA and ATP binding that cause DNA repair
defects, CS results from mutations causing defects in functionally
important conformational dynamics, and TTD involves framework
defects that weaken XPD assembly interactions with TFIIH (Fan
et al., 2008; Kuper et al., 2012; Liu et al., 2008). A major ongoing
question is how the XPB structures and defects match or differ
from the mechanistic disease models proposed from XPD.
Mutational defects in the human Bloom syndrome helicase BLM
cause tumors at early age in diverse tissues (Wu and Hickson,
2003). BLM is one of ﬁve human homologs of RecQ helicase from
Escherichia coli. Whereas the Werner's RecQ helicase includes a
nuclease component activated by coiled-coil assembly (Perry
et al., 2010), BLM pairs with the EXOI nuclease whose DNA complex
has been characterized as a member of the FEN1 superfamily
(Orans et al., 2011; Tsutakawa et al., 2011). The shared biochemis-
tries of BLM and RecG suggest convergent evolution of cellular
function: human BLM fulﬁlls the genomic stabilization role of
RecG (Bianco, 2015). Notably, expression of RecG in human BLM-
deﬁcient cells suppressed both elevated sister chromatid exchange
and the gene cluster instability phenotypes of BLM-deﬁcient cells.
Yet, RecG expression has no impact on these phenotypes in human
cells with functional BLM. The structures of BLM, its disease-
causing mutations, and its interactions with EXO1 as well as their
functional comparisons to RecG will be powerful next steps in
deﬁning BLM functions in genome integrity.
Although DNA replication is accomplished with high ﬁdelity, as
implied by the base-pairing feature of the DNA double helix, the
mutation rate for every replication would be far too high without
the post-replication correction from the DNA mismatch repair
(MMR) pathway. Replication errors are minuscule for high ﬁdelity
replication due to MMR (109) when compared to the numbers of
endogenous DNA damage alone (~70,000/cell/day). This is evident
from the inhibition of MMR by cadmium that causes 2000-fold in-
creases in mutation rates (Jin et al., 2003). High levels of DNA dam-
age are reduced to low levels of mutations by DNA repair, so
alteration of key DNA damage response pathways may prove
even more important than direct DNA damage by mutagens and
an understanding of repair mechanisms has immense biological
and medical value (McMurray and Tainer, 2003). The coordinated
actions of two ATPases (MutS and MutL) initiate the mismatch
repair response and defects in the genes encoding for these pro-
teins have been linked to sporadic and hereditary cancers. Although
MMR has been studied for decades, the mechanism of strand
discrimination has remained elusive in most organisms including
humans. However, biophysical studies on the MutL ATPase and
nuclease are revealing its roles in damaged strand discrimination
and removal during mismatch repair (Guarne and Charbonnier,
2015). Biochemical, biophysical and structural analyses areshowing how MutL aids in distinguishing the newly synthesized
strand from its template and in marking it for removal. In general,
MMR employs a surprisingly large number of conformational states
as part of its activity, based upon X-ray scattering data on compre-
hensive conformational analyses and on the conformations of gold-
nanocrystal labeled DNA bound to MutS, and to both MutS and
MutL (Hura et al., 2013a, 2013b).
The most toxic and mutagenic DNA damage is DNA double-
strand breaks (DSBs), which are repaired by NHEJ or homologous
recombination repair (HRR). Whereas initiation of NHEJ involves
the DNA-PK kinase noted above, initiation of HRR requires the het-
eromeric Mre11-Rad50-Nbs1 (MRN) (Lafrance-Vanasse et al.,
2015). Structures of components and complexes for MRN are
revealing its functions in pathway selection and coordination of
events at collapsed replication forks, where Mre11 nuclease can
excise stalled replication forks (Schlacher et al., 2011) that are un-
protected by BRCA1 or BRCA2 (Schlacher et al., 2012). BRCA1, dis-
cussed above, interfaces with the MRN complex to protect stalled
replication forks from unregulated nuclease activity. Notably, the
dynamics of Rad50 ATP binding and hydrolysis can also control
the Mre11 nuclease and thus DNA end processing versus end teth-
ering (Deshpande et al., 2014), as can the phosphoprotein binding
subunit Nbs1, which binds across the side of Mre11 opposite from
its DNA binding face to allosterically regulate Mre11 activity upon
Nbs1 binding via FHA and BCRT domains to phophoprotein part-
ners (Williams et al., 2009). Furthermore the conformational
sculpting of the DNA needed for the Mre11 endonuclease and
exonuclease activities can be targeted in chemical knockdowns
that reveal licensing and committed steps in HRR (Shibata et al.,
2014). In the future it will be interesting to understand how the
distinct Mre11 and Rad50 DNA binding sites cooperate to bind
and then process DNA substrates and which conformations and in-
teractions may make the optimal targets for possible cancer
therapeutics.
What are the current challenges in DNA repair machines and
where should we look for the next breakthroughs? The ongoing
experimental advances in crystallography and X-ray scattering
noted above promise to provide improved models incorporating
ﬂexibility and bound solvent, which will be important for overall
progress. Computational advances will also be enabling. DNA is a
polyanion, and an appropriate positive patch on the repair enzyme
surface can guide ﬂexible enzyme-substrate recognition while
allowing ﬂexibility of the enzyme binding site (Mol et al., 2000).
Such positive patches are for example seen on both Mre11 and
Rad50 (Hopfner et al., 2001) and were predictive of subsequent
DNA-complex crystal structures (Rojowska et al., 2014; Williams
et al., 2008). Indeed such electrostatic recognition allows regulation
of DNA repair processes by DNA mimicry (Mol et al., 2000; Putnam
et al., 1999) that may act in many DNA repair pathways (Putnam
and Tainer, 2005). In general, electrostatic potential gradients can
increase the rate of interactions (Getzoff et al., 1983) as well as
properly orient two macromolecules for productive collisions
(Roberts et al., 1991). Improvements in computational methods to
includemore accurately electrostatic forces in intermolecular inter-
actions will likely be of great value for understanding DNA damage
response pathway steps and regulation.
In biology, the rate limiting steps of enzymatic pathways are
typically key points for regulation and pathway connections. Rate
limiting steps in DNA repair are often conformational changes
and product release rather than chemistry, as seen for the human
DNA repair nuclease APE1 (Mol et al., 2000). The DNA conforma-
tional change of nucleotide or base ﬂipping discovered in DNA
base repair initiation by uracil-DNA glyocosylase (Slupphaug
et al., 1996) are seen in most of the repair pathways (Huffman
et al., 2005). Blocking base ﬂipping provides a means to inhibit
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mediated conformational change, as seen for Rad50 (Deshpande
et al., 2014), can inhibit speciﬁc functions of multi-functional com-
plexes without having to target the ATP site with its risks of cross-
reactivity and difﬁculty of competing with mM ATP concentrations
in cells.
Where this has been analyzed carefully, DNA repair machines
reveal a stunningly large number of conformational states. Indeed,
DNA repair complexes can be considered as analog computers that
respond to cell cycle states, such as replication and transcription as
well as to the nature of the DNA lesion, as seen for the ATPase com-
plexes of MutS-MutL and Mre11-Rad50 (Hura et al., 2013a,b;
Williams et al., 2010). DNA sculpting, which allows DNA repair nu-
cleases to measure twice-cut once (Tsutakawa et al., 2014), can be a
target for inhibitor design as seen for the DSB repair nuclease
Mre11 (Shibata et al., 2014). Chemical compounds to knock-down
speciﬁc activities based upon structures are likely to be of tremen-
dous value for understanding the effect of chemotherapeutics in
different cell types, resistance mechanisms, and synthetic lethality
where cancer cells may have much greater susceptibility to
knocking-down a given repair step than normal cells. Evidence
for the clinical importance of missing repair activities comes from
the extraordinary responders to clinical trials, e.g. defects in
Rad50 allowed one cancer patient to be cured despite the failure
of the clinical trial for other patients (Al-Ahmadie et al., 2014). Allo-
steric conformations and modular binding sites are becoming
attractive new targets for inhibitor design to dissect functions
and leverage synthetic lethality.
From the conference discussions and papers presented here, it
is evident that the three requirements for life that are the focus of
this special volume of PBMB (replication, repair, and repair coordi-
nation with transcription and replication) merit substantial invest-
ment and intense investigation to link dynamic structures to
functions and examine their relevance to cancer etiology and
future therapies. Taken together these papers on dynamic struc-
tures in DNA damage responses and cancer will therefore be of
substantial interest to researchers as well as funding agencies in
considering priorities to bridge gaps in current knowledge. For
example, the dynamic conformational control of pathways and co-
ordination evident from cross-genomic comparisons coupled to
advanced biophysical methods is surprisingly complex and has
been under appreciated for cell biology and under utilized in ther-
apeutic approaches. The approval of the Poly ADP-Ribose Polymer-
ase (PARP) inhibitor Olaparib to treat ovarian cancer patients with
BRCA1 or BRCA2 mutations provides the ﬁrst cancer drug directed
at genetic instability. This critical ﬁrst step forward in targeting a
defect in DNA break repair also underscores how much remains
to be done in developing the detailed knowledge of structure
and dynamics expected to improve speciﬁcity and to reduce ther-
apeutic failures and resistance (Pearl et al., 2015). From the Inter-
national Workshop on Dynamic Structures in DNA Damage
Responses & Cancer, we know that targeting the DNA damage
response is far from intractable, and there are many promising
and druggable targets to be explored with advanced structural
methods. Major overall goals for structural biophysics going for-
ward will be the mechanistic dissection of the dynamic conforma-
tions coordinating pathways, and of the multiple activities
underlying the functions for DNA repair machines. Achieving these
goals will be aided by the advancement of speciﬁc chemical knock-
downs, which are a major means for the manipulation of speciﬁc
biochemical activities for intracellular targets. Such small molecule
inhibitors promise both to help deﬁne the multiple roles of these
molecular machines in replication, repair and coordination needed
for life and to provide leads for novel advanced cancer
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